Emergence of a VIM-2-producing extensively drug-resistant (XDR) Pseudomonas aeruginosa ST309 in South America: a comparative genomic analysis-Reference-Cited by-同舟云学术

Emergence of a VIM-2-producing extensively drug-resistant (XDR) Pseudomonas aeruginosa ST309 in South America: a comparative genomic analysis

Published:2022-02 Issue:2 Volume:59 Page:106507
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Fonseca Érica L.,Morgado Sérgio M.,Caldart Raquel V.,Freitas Fernanda,Vicente Ana Carolina P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference19 articles.

1. Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395;Petitjean;Microb Genom,2017

2. Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones;Recio;Eur J Clin Microbiol Infect Dis,2020

3. Mechanisms of resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa: results of the GERPA multicenter study;Fournier;Antimicrob Agents Chemother,2021

4. A copper-activated two-component system interacts with zinc and imipenem resistance in Pseudomonas aeruginosa;Caille;J Bacteriol,2007

5. Antibiotic and metal resistance in a ST395 Pseudomonas aeruginosa environmental isolate: a genomics approach;Teixeira;Mar Pollut Bull,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing Pseudomonas aeruginosa;Frontiers in Cellular and Infection Microbiology;2024-06-05

2. Biosynthesis, Characterization and Antimicrobial Response of Silver Nanoparticles Using an Aqueous Extract of Taraxacum officinale;Pharmaceutical Chemistry Journal;2024-05

3. Outbreak of Pseudomonas aeruginosa High-Risk Clone ST309 Serotype O11 Featuring blaPER-1 and qnrVC6;Antibiotics;2024-02-06

4. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group;Clinical Microbiology and Infection;2023-12

5. Public Health Response to Pan-ResistantPseudomonas aeruginosaSequence Type 309 with Tandem Guiana Extended Spectrum β-Lactamases – Genetic Characterization andIn VivoEfficacy Assessment using Translational Murine Model;2023-11-20